Chikungunya is a viral vector-borne disease with no specific treatment of medications. A recent study conducted by Lancet revealed that the risk of death may persist for up to 3 months after recovery. TheHealthSite.com
In a cohort study, Doris K. Nyamwaya, Mark Otiende, and colleagues investigate the incidence of chikungunya virus infection-associated neurological illness among children younger than 16 years of age in Kilifi County, Kenya, between 2014-2018.